Dennis Douroumis

Director
Delta Pharmaceutics Ltd., UK
Professor Dennis Douroumis obtained his BSc in Chemistry and PhD from the Department of Pharmacy at Patras University in Greece. He worked as a postdoctoral fellow (2004) at the Friedrich– Schiller University of Jena, Department of Pharmacy for the development of parenteral formulations of antiepileptic drugs (Novartis Pharma, Basel). He also worked as a team leader (2005) in the development of nano-liposomal formulations and treatment of rheumatoid arthritis by applying photodynamic therapy (Biolitec Pharma GmbH.) Following this, he worked for Phoqus Pharmaceutical plc as a senior scientist at the product development department. Delta’s research focuses on extrusion continuous manufacturing by using hot melt extrusion (HME), extrusion granulation and extrusion crystallization coupled with PAT probes. Delta has filed more than 20 patents spanning 5 family patents worldwide in GB, US, EU, Australia and Canada. The company’s pipeline includes the development of four products based on extrusion processing in collaboration with other pharmaceutical companies.

Events/Masterclasses Dennis Douroumis is currently speaking at

Pharma

3D Printing of Solid Dosage Forms & Medical Devices
18. - 19. November 2021
Online Live Stream 9:00 - 17:00 CET
Join our 3D Printing of Solid Dosage Forms & Medical Devices training to learn about recent developments in printable solid dosage forms and medical devices.

Pharma

Pharmaceutical Cocrystals, Salts & Molecular Modelling
20. - 22. October 2021
Online Live | 9:30 – 13:30 CET
This unique course provides a practical & in-depth understanding of CMC & quality requirements and brings clarifications on global regulation, requirements, compliance & quality concerns.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Dennis Douroumis
Director
Delta Pharmaceutics Ltd., UK
Professor Dennis Douroumis obtained his BSc in Chemistry and PhD from the Department of Pharmacy at Patras University in Greece. He worked as a postdoctoral fellow (2004) at the Friedrich– Schiller University of Jena, Department of Pharmacy for the development of parenteral formulations of antiepileptic drugs (Novartis Pharma, Basel). He also worked as a team leader (2005) in the development of nano-liposomal formulations and treatment of rheumatoid arthritis by applying photodynamic therapy (Biolitec Pharma GmbH.) Following this, he worked for Phoqus Pharmaceutical plc as a senior scientist at the product development department. Delta’s research focuses on extrusion continuous manufacturing by using hot melt extrusion (HME), extrusion granulation and extrusion crystallization coupled with PAT probes. Delta has filed more than 20 patents spanning 5 family patents worldwide in GB, US, EU, Australia and Canada. The company’s pipeline includes the development of four products based on extrusion processing in collaboration with other pharmaceutical companies.
Dennis Douroumis
Description